3 The Chinese Corona vaccine is said to have passed phase three clinical trials, says expert Page all

KOMPAS.com- Three corona vaccines from China, Sinovac, Sinopharm and CanSino, are said to have completed phase 3 clinical trials.

This was transmitted by the General Director of Disease Prevention and Control of the Ministry of Health (Kemenkes) Achmad Yurianto, as reported Kompas.com, Monday (10/19/2020).

“The team has met with vaccine producers who have completed the third phase of clinical trials and this vaccine has even been used in their home country,” Yuri said in an online news conference that was broadcast. Compass TV.

Yuri said: “The goal is the same, that is, to get vaccines that are used safely for our population. Safe in terms of the perspective of the benefits of preventing diseases due to Covid-19,” he continued.

Furthermore, the government also ensures that all three vaccines are safe on the halal side.

Yuri further explained that the three corona vaccines produced by China had also completed clinical trials in several countries.

Sinovac has completed clinical trials in Brazil and China. Meanwhile, in Indonesia, Yuri said that this vaccine will be completed in clinical trials in December.

Meanwhile, Sinopharm has completed phase 3 clinical trials in China, the United Arab Emirates (UAE) and Turkey. In fact, in UAE, this vaccine has obtained the results of the halal test.

In response to this, Indonesian molecular biologist Ahmad Utomo said that currently the public’s understanding of clinical trials of Covid-19 vaccines is quite good.

However, logically, if the clinical trial of the corona virus vaccine has not been completed, the public believes that the vaccine cannot be used.

“This is what the government should be able to explain. Why the clinical trial (phase 3) was not completed, but the vaccine should be used,” Ahmad said when contacted. Kompas.com.

It is necessary to underline that what is the measure of completion of the clinical trials of the phase 3 corona vaccine that are intended for the three corona vaccines in several countries.

SHUTTERSTOCK / PalSand Illustration of crown vaccine

Ahmad explained that the clinical trial of the phase 3 vaccine was conducted to see the difference between the people who received a placebo and the group that received the vaccine, in response to immunity to Covid-19.

“It’s just, the question is, there are a number of reasons why dating seems rushed,” Ahmad explained.

Ahmad further explained that the world is currently facing a very high demand for vaccines, while the number of vaccine producers is small.

“Globally, for such a short period of time, it is impossible for us to vaccinate everyone. Because the demand is very high while the supply is low, of course the market price is also expensive,” Ahmad explained. .

Also read: There is still no powerful vaccine against Covid-19, why do vaccines start in November?

Therefore, Ahmad suspects that the possibility of the government’s efforts to buy the corona vaccine from the three producers is made as a precautionary measure to save the Indonesian population in the face of this pandemic.

However, Ahmad recalled that there are risks or consequences that must be faced. He revealed that there are two possibilities related to the effectiveness of the vaccine that will be administered later.

“First, the vaccine could stop the infection. Because of indeed, people can return to normal life. Another possibility, vaccines cannot stop transmission, “Ahmad said.

Therefore, Ahmad recalled the need for caution and, most importantly, transparency of clinical trial data that the vaccine is ready and safe for use.

“However, everyone returns to BPOM as the last line of defense. Although the corona vaccine will be available later, it cannot be used in regulations immediately, before there is a green light from BPOM,” Ahmad added.